Econ Financial Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Econ Financial Services's XBI Position: Q3 2025 in Review
Econ Financial Services sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 24,367 shares — an estimated $2.02M sold.
Econ Financial Services first reported a position in XBI in Q1 2022 and held it in 5 quarters. The position peaked at $2.06M in Q1 2025. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.
- Econ Financial Services reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
- Econ Financial Services sold 24,367 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $2.02M.
- Econ Financial Services first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and held it in 5 quarters.
- Econ Financial Services's State Street SPDR S&P Biotech ETF position peaked at $2.06M in Q1 2025.
- 656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.
Based on Econ Financial Services's 13F filing for Q3 2025, filed 21 Oct 2025.